Galectins are a group of animal lectins characterized by their specificity for -galactosides.
Introduction
Galectins comprise a group of animal lectins that specifically bind to -galactosides and are characterized by an evolutionarily conserved sequence motif in the carbohydrate-binding site [1] [2] [3] . Galectins are involved in a wide variety of biological processes, including development, cell differentiation, tumor metastasis, apoptosis, RNA splicing, and immune regulation [4, 5] .
Interactions between lectins and their carbohydrate ligands play important roles in various biological systems. Although the basic sugar structure recognized by mammalian galectins such as human galectin-1 (hGal-1) is the N-acetyllactosamine disaccharide unit, the sugar-binding specificity of each galectin can be enhanced by branched, repeated, or substituted glycans [6, 7] , suggesting that galectins can interact with a variety of endogenous ligands possessing different carbohydrate structures.
Gal-2 is a member of the galectin family that was first found to be highly expressed in gastric cells, predominantly in epithelial cells of the rat stomach [8] . Gastric mucous cells also exhibit strong Gal-2 immunoreactivity, with expression observed in the small intestine [9] and Gal-2 mRNA detected in human stomach [10] . The amelioration of acute and chronic colitis in mice by Gal-2 overexpression [11] , and reduced Gal-2 expression in humans associated with lymph node metastasis in gastric cancer [12] and in Helicobacter-induced gastric cancer progression [13] suggest that Gal-2 has a protective function in the gastrointestinal tract.
Nitric oxide (NO) is an intracellular chemical messenger that is synthesized from L-
arginine by NO synthase (NOS) and participates in signal transduction in variety of mammalian cell types, including neurons and vascular endothelial cells [14] . In contrast to enzymatic formation by NOS, NO is generated in the stomach by non-enzymatic acid reduction of salivary nitrite to exert various physiological functions in the gastrointestinal tract [15] [16] [17] [18] , including functioning as a barrier in the stomach [19] [20] [21] . Furthermore, orally administered nitrate ameliorated dextran sulfate sodium-induced acute experimental colitis in mice [22] . S-nitrosylation -which involves the coupling of an NO group to the reactive thiol of a Cys residue in a polypeptide -is an important post-translational modification detected in a variety of proteins [23] ; thus, continuous exposure of gastric mucosa to high concentrations of NO is predicted to result in the S-nitrosylation of many proteins that could contribute to the protection of the stomach lining.
Gal-2 was identified through a screen of mouse gastric mucosal proteins that are uniquely sensitive to S-nitrosylation [24] , suggesting Gal-2 exerts a protective effect because of S-nitrosylation by NO in the stomach. In this study, recombinant mouse (m)Gal-2 was used to test whether the protein is the target of S-nitrosylation and examine the biochemical effects thereof.
Material and methods

Construction of wild-type and mutant recombinant mGal-2 expression plasmids -A DNA
fragment encoding mGal-2 was amplified by PCR using mouse stomach first strand cDNA (MD-05, GenoStaff Co., Ltd., Tokyo, Japan) as a template. Forward and reverse primer sequences containing NdeI and BamHI sites (underlined), respectively, were 5'-CATATGTCGGAGAAATTTGAGGTC-3' and 5'-GGATCCGGCTAAGGTCTTCTGAGG-3', respectively. The PCR product was ligated into the pCR2.1-TOPO vector using the TOPO TA cloning kit (Invitrogen, Carlsbad, CA, USA). The pCR2.1-TOPO-mGal-2 plasmid was digested with NdeI and BamHI, and the DNA fragment was inserted into the corresponding restriction sites of the pET21a vector for protein expression.
cDNAs for mGal-2 mutants C57M, C75S, and C57M/C75S were generated by PCR using the pCR2.1-TOPO-mGal-2 plasmid and the following primers (substitution sites are underlined), as previously described [25] : C57M, 5'-ATGAACACCAGTGAAGGTG-3' and 5'-GACAATGGTGGATTCATC-3'; C75S, 5'-AGCTTCAGTCCAGGGTCA-3' and 5'-CATGTGATTTTCTCGTTG-3'; C57M/C75S, 5'-CATTGTCATGAACACCAGTGAAGG-3' and 5'-GTGGATTCATCGAAGCGAGG-3'. The PCR products were inserted into the pET21a vector for protein expression as described above.
Purification of recombinant mGal-2 -The expression and purification of recombinant wildtype and mutated forms (C57M, C75S, and C57M/C75S) of mGal-2 were performed as previously described [26] .
Measurement of protein concentration -Protein concentration was determined by Bradford's method [27] using bovine serum albumin as standard.
Estimation of sulfhydryl groups -The number of free sulhydryl groups on Cys residues of recombinant mGal-2 proteins was estimated using Ellman's reagent (5,5'-dithio-bis- [2- nitrobenzoic acid]) and by measuring the absorbance at 412 nm [28] using Cys as standard.
S-nitrosylation -The wild-type and mutated forms of mGal-2 protein (1 mg/ml) were incubated in ethylenediamine tetraacetic acid-phosphate-buffered saline (EDTA-PBS) (20 mM NaH 2 PO 4 , 150 mM NaCl, 1 mM EDTA, pH 7.2) with or without 1 mM Snitrosocysteine (CysNO) for 60 min at room temperature in the dark with constant rotation.
CysNO was prepared at the time of use by mixing equal amounts of 200 mM Cys in 100 mM HCl and 210 mM sodium nitrite in 100 mM HCl. To remove unreacted CysNO, samples were ultrafiltered with Amicon Ultra (Millipore, Billerica, MA, USA).
Saville-Griess assay -The number of S-nitrosylated molecules was measured using the Saville-Griess assay as previously described [29] . Briefly, S-nitrosylated mGal-2 (wild-type or mutated forms) was incubated with 1% sulfanilamide and 0.1% N-(naphthyl)ethylenediaminde dihydrochloride in the presence 4 mM CuCl 2 for 20 min and Snitrosylated content was measured photometrically at 540 nm. The amount was calculated using defined concentrations of S-nitrosoglutathione as a standard.
Oxidation of mGal-2 by hydrogen peroxide (H 2 O 2 ) -H 2 O 2 concentration was measured at
240 nm ( 240 = 43.6 M −1 cm −1 ). S-nitrosylated mGal-2 (0.1 mg/ml, 1 ml) was incubated with 10 mM H 2 O 2 for 2 h in the dark followed by addition of catalase from bovine liver at a final concentration of 100 U/ml (Wako Pure Chemical Industries, Osaka, Japan) to quench excess
Binding of Gal-2 to lactose -S-nitrosylated mGal-2 treated with H 2 O 2 was applied to a lactose-immobilized agarose (J-Oil Mills, Inc., Tokyo, Japan) column (bed volume 1 ml).
After washing with 5 ml EDTA-PBS, the bound mGal-2 was eluted with 2 ml EDTA-PBS containing 0.1 M lactose. The eluted fraction was collected (0.5 ml/fraction), and each fraction was resolved by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) followed by staining with Bio-Safe Coomassie Brilliant Blue (Bio-Rad, Hercules, CA, USA).
Frontal affinity chromatography analysis -Frontal affinity chromatography was carried out as previously described [30] [31] [32] . Briefly, pyridylaminated (PA)-oligosaccharides were dissolved in EDTA-PBS at a concentration of 5 nM and applied to the column (10 × 4.0 mm; 0.126 ml/ bed volume) through a 2-ml sample loop connected to a Rheodyne 7725i injector.
The flow rate was controlled by a LC-20AT pump (Shimadzu, Kyoto, Japan) at 0.25 ml/min.
The sample loop and column were immersed in a 20°C water bath. Elution of PAoligosaccharide from the column was monitored with a Shimadzu RF-10A XL fluorescence detector at 380 nm (with excitation at 310 nm). The elution volume of the PAoligosaccharide of interest was determined as previously described. PA-rhamnose was used to determine the elution volume of a PA-oligosaccharide with no affinity for galectins. The PA-oligosaccharides used to verify the sugar-binding profile of mGal-2 were PA-001, 002, 004, 022, 023, 041, 042, 043, 044, 045, 046, 047, and 049, whose structures were described in our previous reports [31, 33] .
Hemagglutination assay -Hemagglutination activity was measured as previously reported [34] . Briefly, a 25-μl sample of S-nitrosylated mGal-2 was serially diluted 2-fold in a 96-well V-shaped microtiter plate, followed by the addition of either 50 μl of EDTA-PBS or 20 mM 
Results
S-nitrosylation of recombinant mGal-2 -
Sugar-binding capacity of mGal-2 is unaffected by S-nitrosylation -
To determine the effect of S-nitrosylation on mGal-2 function, the sugar-binding capacity of mGal-2 was assessed.
Following S-nitrosylation, the protein was exposed to a lactose-immobilized agarose column.
In the absence of S-nitrosylation, recombinant mGal-2 was adsorbed to the column and eluted with 0.1 M lactose (Fig. 1a) . Similarly, S-nitrosylated mGal-2 was adsorbed to the column and eluted with 0.1 M lactose (Fig. 1b) , suggesting that S-nitrosylation did not alter the -galactoside-binding capacity of mGal-2. To examine the effects of S-nitrosylation on sugarbinding by mGal-2 in more detail, recombinant mGal-2 protein with or without Snitrosylation was immobilized to agarose resin and analyzed by frontal affinity chromatography. There were no significant changes in the binding affinity of mGal-2 to the PA-oligosaccharides examined (Fig. 1c) . Furthermore, when recombinant and S-nitrosylated mGal-2 were labeled with Cy3 and their sugar-binding profiles were analyzed by glycoconjugate microarray [36] , there were no significant differences detected (data not shown).
Dimerization of mGal-2 is unaffected by S-nitrosylation -mGal-2 dimerization was analyzed
by incubating the protein with the crosslinker BS 3 , followed by SDS-PAGE and Oriole staining (Fig. 2) . A similar dimer-monomer ratio was observed for mGal-2 with and without S-nitrosylation.
H 2 O 2 -induced mGal-2 inactivation is abrogated by S-nitrosylation -Unlike untreated mGal-2
( Fig. 1a) , recombinant mGal-2 was inactivated by treatment with 10 mM H 2 O 2 for 2 h, as evidenced by the absence of interaction between H 2 O 2 -treated mGal-2 and immobilized lactose in the agarose column (Fig. 3a) . In contrast, S-nitrosylated mGal-2 was able to bind to the lactose-immobilized agarose column even after H 2 O 2 treatment and was eluted with lactose ( Fig. 3b) , suggesting that the oxidative inactivation of mGal-2 was prevented by Snitrosylation. Similarly, S-nitrosylation preserved the hemagglutination activity of mGal-2.
As shown in Figure 4 , the hemagglutination activity was lost upon exposure to H 2 O 2 prior to the addition of a rabbit erythrocyte suspension (line C), even when the mGal-2 concentration 
Discussion
In this study, the ratio of recombinant wild-type mGal-2 S-nitrosylated by CysNO was calculated as 1.07 moles of S-nitrosylation/mole of -SH, suggesting that the two Cys residues (Cys 57 and Cys 75 ) were both fully S-nitrosylated, which was supported by the fact that no Snitrosylation was observed for the C57M/C75S mutant lacking Cys. When equivalent amounts of wild-type or mutated protein were used for S-nitrosylation, the ratio was Since the generated mutants were adsorbed to -galactoside-containing columns and eluted with lactose, and no differences in sugar-binding profiles were detected by frontal affinity chromatography-implying that sugar-binding profiles were similar between mutant and wild-type mGal-2-it was concluded that the mutants have the same biochemical properties as wild-type mGal-2.
Cys 57 and Cys 75 are highly conserved in Gal-2 across mammals. According to the X-ray crystal structure of human Gal-2 in complex with lactose [37] , Cys 57 is located in the middle of the carbohydrate-binding cassette with its side chain sulfhydryl group (a potential site for S-nitrosylation) protruding to the side opposite the -sheet that binds lactose.
We speculated that S-nitrosylation could alter the sugar-binding capacity of mGal-2, especially at Cys 57 ; S-nitrosylated mGal-2 was therefore assessed for its capacity to bind to lactose-immobilized agarose columns and was also analyzed by frontal affinity chromatography and glycoconjugate microarray. There were no differences in the sugarbinding profile or hemagglutination activity between mGal-2 with and without Snitrosylation, even though Cys 57 appeared to be S-nitrosylated. These combined with the results from the BS 3 crosslinking experiment indicate that S-nitrosylation does not affect mGal-2 dimerization; this is likely because-based on the crystal structure of human Gal-2-the two Cys residues are distant from the surface that engages in dimer formation.
However, an interesting difference between mGal-2 with and without and Snitrosylation was observed when the microtiter V-plate was left on the bench after the measurement of hemagglutination activity: erythrocytes remained hemagglutinated by Snitrosylated mGal-2 but not by mGal-2 after a few days at room temperature. Since it was assumed that the loss of hemagglutination activity was due to mGal-2 oxidation, mGal-2 was oxidized by treatment with H 2 O 2 , one type of reactive oxygen species (ROS) produced in the stomach upon inflammation caused by Helicobacter pylori or other types of infection [38] . It is possible that S-nitrosylation of the two Cys residues inhibited the oxidation of these residues. Some proteins such as protein-tyrosine phosphatase 1B are protected against oxidation-induced inactivation by S-nitrosylation of Cys residues [39] . Since Gal-2 exists predominantly in the gastrointestinal tract where it has a protective role, NO produced in the stomach may induce S-nitrosylation of Gal-2, thereby protecting the protein from oxidation by ROS so that it retains its activity.
On the other hand, a very small amount of S-nitrosylated mGal-2 lost lectin activity by oxidation and were therefore not retained by the lactose-immobilized agarose column, possibly because H 2 O 2 treatment may have resulted in oxidation of residues other than the two Cys residues.
Gal-1 has six Cys residues whose oxidative states dictate Gal-1 function [40] [41] [42] [43] [44] . On the other hand, the monomer-dimer equilibrium of Gal-1 regulates its sensitivity to oxidative inactivation [45] . Furthermore, human Gal-1 may also be a substrate for S-nitrosylation [46] .
Taken together, these results suggest that S-nitrosylation is an important modification for regulating galectin activity in animals. 
